What is the share price of Colinz Laboratories Ltd (COLINZ) today?
The share price of COLINZ as on 21st September 2026 is ₹74.80. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Colinz Laboratories Ltd (COLINZ) share?
The past returns of Colinz Laboratories Ltd (COLINZ) share are- Past 1 week: 3.45%
- Past 1 month: -7.54%
- Past 3 months: 20.33%
- Past 6 months: 58.71%
- Past 1 year: 67.95%
- Past 3 years: 79.68%
- Past 5 years: 275.05%
What are the peers or stocks similar to Colinz Laboratories Ltd (COLINZ)?
The peers or stocks similar to Colinz Laboratories Ltd (COLINZ) include:What is the market cap of Colinz Laboratories Ltd (COLINZ) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Colinz Laboratories Ltd (COLINZ) is ₹17.95 Cr as of 21st September 2026.What is the 52 week high and low of Colinz Laboratories Ltd (COLINZ) share?
The 52-week high of Colinz Laboratories Ltd (COLINZ) is ₹87.91 and the 52-week low is ₹36.11.What is the PE and PB ratio of Colinz Laboratories Ltd (COLINZ) stock?
The P/E (price-to-earnings) ratio of Colinz Laboratories Ltd (COLINZ) is 35.90. The P/B (price-to-book) ratio is 1.79.Which sector does Colinz Laboratories Ltd (COLINZ) belong to?
Colinz Laboratories Ltd (COLINZ) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Colinz Laboratories Ltd (COLINZ) shares?
You can directly buy Colinz Laboratories Ltd (COLINZ) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Colinz Laboratories Ltd
COLINZ Share Price
BSE₹74.804.97% (+3.54)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
COLINZ Stock Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
AvgCan be considered moderately valued vs the market
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
COLINZ Performance & Key Metrics
COLINZ Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 6.41 | 1.79 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 47.20 | 5.92 | 0.48% |
COLINZ Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
COLINZ Company Profile
Colinz Laboratories Ltd is engaged in the manufacturing and marketing of pharmaceutical formulations.
SUNPHARMA
PE Ratio
38.40
38.40
1Y Return
11.45%
11.45%
Buy Reco %
93.33
93.33
TORNTPHARM
PE Ratio
85.10
85.10
1Y Return
35.67%
35.67%
Buy Reco %
81.48
81.48
ZYDUSLIFE
PE Ratio
22.96
22.96
1Y Return
10.70%
10.70%
Buy Reco %
55.56
55.56
CIPLA
PE Ratio
29.04
29.04
1Y Return
11.64%
11.64%
Buy Reco %
62.86
62.86
LAURUSLABS
PE Ratio
118.79
118.79
1Y Return
111.64%
111.64%
Buy Reco %
58.33
58.33
COLINZ Forecast
COLINZ Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
COLINZ
COLINZ
Income
Balance Sheet
Cash Flow
Quarterly Normal View
COLINZ Income Statement
COLINZ Income Statement
Quarterly Normal View
| Quarter | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | mar 2026 | jun 2026 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1.74 | 1.81 | 1.94 | 1.54 | 1.53 | 1.64 | 1.55 | 1.51 | 1.92 | 4.13 | ||||||||||
Operating & Other expenses | 1.50 | 1.59 | 1.69 | 1.40 | 1.35 | 1.43 | 1.31 | 1.33 | 1.66 | 1.18 | ||||||||||
EBITDA | 0.24 | 0.22 | 0.25 | 0.14 | 0.18 | 0.21 | 0.24 | 0.18 | 0.26 | 2.95 | ||||||||||
| Depreciation/Amortization | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | ||||||||||
| PBIT | 0.21 | 0.19 | 0.22 | 0.11 | 0.15 | 0.17 | 0.20 | 0.14 | 0.22 | 2.91 | ||||||||||
| Interest & Other Items | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | ||||||||||
| PBT | 0.20 | 0.18 | 0.21 | 0.10 | 0.13 | 0.16 | 0.19 | 0.13 | 0.21 | 2.90 | ||||||||||
| Taxes & Other Items | 0.06 | 0.05 | 0.05 | 0.05 | -0.03 | 0.04 | 0.05 | 0.04 | 0.04 | 0.50 | ||||||||||
| Net Income | 0.14 | 0.13 | 0.16 | 0.05 | 0.16 | 0.12 | 0.14 | 0.09 | 0.17 | 2.40 | ||||||||||
| EPS | 0.54 | 0.54 | 0.62 | 0.21 | 0.60 | 0.47 | 0.56 | 0.33 | 0.68 | 9.53 |
COLINZ Company Updates
COLINZ Stock Peers
COLINZ Past Performance & Peer Comparison
COLINZ Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Colinz Laboratories Ltd | 35.90 | 1.79 | — |
| Sun Pharmaceutical Industries Ltd | 38.40 | 5.26 | 0.87% |
| Torrent Pharmaceuticals Ltd | 85.10 | 10.47 | 0.70% |
| Zydus Lifesciences Ltd | 22.96 | 3.91 | 0.09% |
COLINZ Stock Price Comparison
Compare COLINZ with any stock or ETFCompare COLINZ with any stock or ETF
COLINZ
COLINZ Holdings
COLINZ Shareholdings
COLINZ Promoter Holdings Trend
COLINZ Promoter Holdings Trend
Decreased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has decreased by 15.40%
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
COLINZ Institutional Holdings Trend
COLINZ Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
COLINZ Shareholding Pattern
COLINZ Shareholding Pattern
COLINZ Shareholding History
COLINZ Shareholding History
Foreign Institutions
smallcases containing COLINZ stock
smallcases containing COLINZ stock
Looks like this stock is not in any smallcase yet.
COLINZ Events
COLINZ Events
COLINZ Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
COLINZ has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
COLINZ Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
COLINZ has not given any dividends in last 5 years
COLINZ Dividends
COLINZ Dividends
Hmm, looks like data is unavailable here. Please come back after some timeCOLINZ Stock News & Opinions
COLINZ Stock News & Opinions
Articles & Videos
Earnings
Earnings
Colinz Laboratories standalone net profit rises 1900.00% in the June 2026 quarterNet profit of Colinz Laboratories rose 1900.00% to Rs 2.40 crore in the quarter ended June 2026 as against Rs 0.12 crore during the previous quarter ended June 2025. Sales declined 21.02% to Rs 1.24 crore in the quarter ended June 2026 as against Rs 1.57 crore during the previous quarter ended June 2025. ParticularsQuarter EndedJun. 2026Jun. 2025% Var. Sales1.241.57 -21 OPM %4.848.28 - PBDT0.180.20 -10 PBT0.140.16 -13 NP2.400.12 1900 Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Corporate
Colinz Laboratories to conduct board meetingColinz Laboratories will hold a meeting of the Board of Directors of the Company on 30 July 2026.
2 months agoCapital Market - Live
Earnings
Earnings
Colinz Laboratories standalone net profit rises 13.33% in the March 2026 quarterNet profit of Colinz Laboratories rose 13.33% to Rs 0.17 crore in the quarter ended March 2026 as against Rs 0.15 crore during the previous quarter ended March 2025. Sales rose 20.69% to Rs 1.75 crore in the quarter ended March 2026 as against Rs 1.45 crore during the previous quarter ended March 2025. For the full year,net profit rose 2.00% to Rs 0.51 crore in the year ended March 2026 as against Rs 0.50 crore during the previous year ended March 2025. Sales declined 5.97% to Rs 6.14 crore in the year ended March 2026 as against Rs 6.53 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales1.751.45 21 6.146.53 -6 OPM %5.146.21 -6.687.50 - PBDT0.250.15 67 0.840.75 12 PBT0.210.12 75 0.680.62 10 NP0.170.15 13 0.510.50 2 Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Corporate
Colinz Laboratories to convene board meetingColinz Laboratories will hold a meeting of the Board of Directors of the Company on 29 April 2026.
5 months agoCapital Market - Live
Earnings
Earnings
Colinz Laboratories standalone net profit rises 60.00% in the December 2025 quarterNet profit of Colinz Laboratories rose 60.00% to Rs 0.08 crore in the quarter ended December 2025 as against Rs 0.05 crore during the previous quarter ended December 2024. Sales declined 2.72% to Rs 1.43 crore in the quarter ended December 2025 as against Rs 1.47 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales1.431.47 -3 OPM %6.294.08 - PBDT0.160.13 23 PBT0.120.10 20 NP0.080.05 60 Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Corporate
Colinz Laboratories to hold board meetingColinz Laboratories will hold a meeting of the Board of Directors of the Company on 24 January 2026.Powered by Capital Market - Live
8 months agoCapital Market - Live
Corporate
Corporate
Colinz Laboratories to conduct board meetingColinz Laboratories will hold a meeting of the Board of Directors of the Company on 17 January 2026.Powered by Capital Market - Live
8 months agoCapital Market - Live
Corporate
Corporate
Colinz Laboratories to convene board meetingColinz Laboratories will hold a meeting of the Board of Directors of the Company on 17 January 2026.Powered by Capital Market - Live
8 months agoCapital Market - Live
Corporate
Corporate
Colinz Laboratories to conduct board meetingColinz Laboratories will hold a meeting of the Board of Directors of the Company on 27 November 2025.Powered by Capital Market - Live
9 months agoCapital Market - Live
Corporate
Corporate
Colinz Laboratories to conduct board meetingColinz Laboratories will hold a meeting of the Board of Directors of the Company on 11 November 2025.Powered by Capital Market - Live
10 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 0.84%, vs industry avg of 11.76%
Over the last 5 years, market share stayed at 0%
Over the last 5 years, net income has grown at a yearly rate of 20.11%, vs industry avg of 10.45%